Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 76,194 | 38,185 | 73,400 | 91,078 | 68,490 |
| Depreciation Amortization | 49,049 | 24,340 | 109,903 | 82,792 | 55,221 |
| Income taxes - deferred | 5,203 | 5,275 | -51,107 | -18,825 | -13,417 |
| Accounts receivable | 23,333 | 22,392 | 34,132 | 5,271 | 20,940 |
| Accounts payable and accrued liabilities | -8,107 | -2,115 | -13,954 | -639 | -29 |
| Other Working Capital | -40,996 | -42,849 | 11,539 | -10,031 | 2,458 |
| Other Operating Activity | 5,320 | -17,643 | 123,643 | 39,709 | 14,572 |
| Operating Cash Flow | $109,996 | $27,585 | $287,556 | $189,355 | $148,235 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 1,085 | 1,085 | 1,085 |
| PPE Investments | -11,284 | -5,363 | -31,006 | -26,116 | -15,993 |
| Purchase Of Investment | 0 | 0 | -15,000 | -15,000 | -15,000 |
| Other Investing Activity | 5,968 | 5,968 | 9,738 | 4,442 | 3,192 |
| Investing Cash Flow | $-5,316 | $605 | $-35,183 | $-35,589 | $-26,716 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 104,000 | 38,000 | N/A |
| Debt Repayment | -86,000 | -46,000 | -77,000 | -27,000 | -19,000 |
| Common Stock Issued | 28,234 | 23,495 | 51,739 | 45,513 | 30,641 |
| Common Stock Repurchased | -24 | -24 | -275,731 | -175,674 | -75,628 |
| Dividend Paid | -24,914 | -12,444 | -50,391 | -38,004 | -25,424 |
| Other Financing Activity | -10,486 | -9,231 | -6,522 | -6,288 | -5,997 |
| Financing Cash Flow | $-93,190 | $-44,204 | $-253,905 | $-163,453 | $-95,408 |
| Exchange Rate Effect | -797 | -1,210 | 11,927 | -1,434 | -353 |
| Beginning Cash Position | 162,186 | 162,186 | 151,791 | 151,791 | 151,791 |
| End Cash Position | 172,879 | 144,962 | 162,186 | 140,670 | 177,549 |
| Net Cash Flow | $10,693 | $-17,224 | $10,395 | $-11,121 | $25,758 |
| Free Cash Flow | |||||
| Operating Cash Flow | 109,996 | 27,585 | 287,556 | 189,355 | 148,235 |
| Capital Expenditure | -11,284 | -5,363 | -31,006 | -26,116 | -15,993 |
| Free Cash Flow | 98,712 | 22,222 | 256,550 | 163,239 | 132,242 |